Featured News
The Promise of TIL:
Dr. Betof-Warner's First Patient Infusion
In February 2024, the Food and Drug Administration (FDA) greenlit the first cellular therapy to treat solid tumors…Thanks to the partnership with Stanford’s Advanced Melanoma Program and Blood and Marrow Transplantation (BMT) & Cellular Therapy Program. Stanford treated the first patient in the world with the approved therapy in April of this year. Click here for the full article
Entering a New Era of TIL Cell Therapy Innovation
Cytotherapy December 28, 2024;
TIL Working Group members Rodabe Amaria, Krishna Komanduri, and Adam Schoenfeld, with colleagues, published this recent review of the current state of TIL cell therapy and innovations in the field. Click here for the full article
